Plain-English translation of NCT07274163 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This is a registry study — meaning researchers will gather and organize medical information from lung cancer patients treated at Policlinico San Matteo hospital from 2019 to 2035. Rather than testing a new drug, the study uses real-world patient data to understand how current treatments work, how people respond to them, and what factors help doctors choose the best therapy for each person.
Lung cancer is a serious disease, but newer treatments like targeted therapies and immunotherapy have improved survival for many patients. By collecting and studying data from hundreds of patients in real-world practice, researchers hope to learn what works best for different people and use those insights to improve care and future research.
You likely qualify if…
You likely don't qualify if…
If you are a current patient at the hospital, you would consent to have your medical records and treatment information collected as part of the registry — this happens alongside your regular cancer care. If you are a former patient, researchers would access your existing medical records with your permission. Either way, your information would be securely stored and studied to help improve lung cancer treatment for future patients.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Enrollment target
~1,500 participants
Started
January 2019
Primary completion
December 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Francesco Agustoni
Fondazione IRCCS Policlinico San Matteo di Pavia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.